Clene Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Clene Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-09-30 was $88.00K.
- Clene Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $36.00K.
- Clene Inc. stock issued during period, value, stock options exercised for the quarter ending 2022-06-30 was $17.00K, a 70.69% decline year-over-year.
- Clene Inc. stock issued during period, value, stock options exercised for the quarter ending 2022-03-31 was $267.00K, a 434.00% increase year-over-year.
- Clene Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $124.00K.
- Clene Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $310.00K, a 30.02% decline from fiscal 2021.
- Clene Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $443.00K, a 467.95% increase from fiscal 2020.
- Clene Inc. stock issued during period, value, stock options exercised for fiscal 2020 was $78.00K, a 680.00% increase from fiscal 2019.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2024-12-31 | $124.00K 10-K · filed 2026-03-17 | |
| 2024-09-30 | $88.00K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $36.00K 10-Q · filed 2025-11-13 | |
| 2022-12-31 | $310.00K 10-K · filed 2024-03-13 | |
| 2022-06-30 | $17.00K 10-Q · filed 2023-11-07 | |
| 2022-03-31 | $267.00K 10-Q · filed 2023-11-07 | |
| 2021-12-31 | $443.00K 10-K · filed 2023-03-13 | |
| 2021-09-30 | $319.00K 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $58.00K 10-Q · filed 2022-11-07 | |
| 2021-03-31 | $50.00K 10-Q · filed 2022-11-07 | |
| 2020-12-31 | $78.00K 10-K · filed 2022-03-11 | |
| 2020-09-30 | $2.00K 10-Q · filed 2021-11-08 | |
| 2019-12-31 | $10.00K 10-K · filed 2021-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |